DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Aapro M, Rugo H, Rossi G, Rizzi G, Borroni ME, Bondarenko I. et al.
A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy.
Ann Oncol 2014;
25: 1328-33
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.